Ever been stuck on the road far from home with a breakdown? Not fun. So imagine getting an email or text warning weeks or months before a starter quits, a battery dies or a fuel pump fails. Some of ...
Zacks Investment Research on MSN
Sera Prognostics, Inc. (SERA) reports Q2 loss, misses revenue estimates
Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.16 per share a year ago. These ...
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today ...
Secured landmark Illinois Medicaid coverage legislation, validating the clinical and economic value of PreTRM Test-guided care for tens of thousands of annual pregnancies. Exceeded 2026 payer ...
Aligning Management Team given New Refined Commercial Focus on Institutions Starting with Recent Appointment of Board Member Zhenya Lindgardt as Interim President and CEO Engages Leading Strategy ...
View Sera Prognostics, Inc. Class A SERA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to provide early, pivotal pregnancy ...
SALT LAKE CITY, Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by ...
The company targets active discussions in 15–17 states and aims to run 5–7 partner programs by the end of 2026, representing 58–60% of U.S. births. Aerts explained, "We have budgeted the same -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results